Company: EDSA
Filing Date: 2025-09-30
Form Type: 8-K
Source: 0001171843-25-006188
Chunk: 1

Company: Edesa Biotech, Inc.
Filing Date: 2025-09-30
Form: 8-K
Item: Item 1.01
Chunk 1
---
 their entirety by reference to the Agreement, a copy of which is filed
with the Company’s annual report on Form 10-K filed on December 15, 2023, and the Amendment, a copy of which will be filed
with the Company’s annual report on Form 10-K for the fiscal year ending September 30, 2025.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance
Sheet Arrangement of a Registrant

The information set forth under Item 1.01 is incorporated into this Item 2.03 by reference.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                Edesa Biotech, Inc.                               
  Date: September 30, 2025      By:                      /s/ Peter J. Weiler      
                                Name:                    Peter J. Weiler          
                                Title:                   Chief Financial Officer